Detalhe da pesquisa
1.
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer.
Invest New Drugs
; 37(2): 331-337, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402678
2.
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy.
Prostate
; 78(13): 1035-1041, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882332
3.
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma.
Br J Cancer
; 119(2): 160-163, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795307
4.
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
J Transl Med
; 16(1): 184, 2018 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973204
5.
Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study.
Invest New Drugs
; 36(6): 1085-1092, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191523
6.
Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review.
Expert Rev Anticancer Ther
; 23(7): 731-744, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194261
7.
Retrospective Outcomes of a New Acupuncture Service at a Comprehensive Cancer Center.
J Integr Complement Med
; 29(10): 674-682, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37252748
8.
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.
JCO Precis Oncol
; 7: e2300131, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467457
9.
The modern therapeutic & imaging landscape of metastatic prostate cancer: a primer for radiologists.
Abdom Radiol (NY)
; 47(2): 781-800, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34783876
10.
Biosimilar strategic implementation at a large health system.
Am J Health Syst Pharm
; 79(4): 268-275, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752608
11.
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study.
Eur Urol
; 85(4): 398-400, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485300
12.
Emerging biomarkers and targeted therapies in urothelial carcinoma.
Ann Transl Med
; 6(12): 250, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30069452
13.
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and Radiation.
Urology
; 113: e1-e2, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203190
14.
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Target Oncol
; 13(4): 495-500, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974386
15.
ATM/RB1 mutations predict shorter overall survival in urothelial cancer.
Oncotarget
; 9(24): 16891-16898, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682192
16.
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire.
J Immunother Cancer
; 6(1): 112, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352626
17.
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 16(5): 413-419.e1, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30172552
18.
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies.
Target Oncol
; 13(3): 353-361, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623487
19.
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.
J Clin Invest
; 128(8): 3333-3340, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29939161
20.
Emerging immunotherapy in advanced renal cell carcinoma.
Urol Oncol
; 35(12): 687-693, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889919